Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Buy from Neutral at BofA/Merrill with analyst Sumant Kulkarni said the last night's unfavorable Court ruling is not a surprise and the company has already lowered its financial outlook on higher generic price erosion. Now that the ruling is out of the way, the analyst views Teva risk/reward as favorable and notes shares are down 58% since July 16, 2016 when it provided a more optimistic outlook. Over time, Kulkarni expects investors will be rewarded from Teva's leading generic pipeline and underappreciated brand pipeline. 2. CBOE Holdings (CBOE) upgraded to Buy from Underperform at BofA/Merrill with analyst Michael Carrier upgrading CBOE Holdings two notches to Buy from Underperform and raising its price target to $85 from $74. The analyst sees multiple sources of upside to accelerate earnings driven by the BATS deal, increased capital deployment, rising volatility off of historic lows, and potential US tax reform. 3. Monro Muffler (MNRO) upgraded to Buy from Hold at Gabelli with analyst Carolina Jolly citing valuation, acquisition growth, and a history of execution. 4. Tupperware Brands (TUP) upgraded to Neutral from Sell at B. Riley with analyst Linda Bolton Weiser increasing her price target for the shares to $54 from $47. 5. ViaSat (VSAT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Andrew Spinola saying the valuation is attractive for "strong" medium- and long-term growth from the Viasat-2 and Viasat-3 launches. The analyst expects EBITDA growth of 41% and 21% in fiscal 2019 and fiscal 2020, respectively. He raised his price target for the shares to $94-$98 from $76-$78. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.